FEATURES
Proton beam therapy could transform mesothelioma treatment
Clinician researchers at UCLH and UCL are leading a major UK clinical trial to test whether proton beam therapy (PBT) can significantly improve survival for patients with the rare and aggressive cancer of the lining of the lung.
The HIT-MESO...
Chemically ‘stapled’ peptides used to target difficult-to-treat cancers
Researchers at the University of Bath have developed a new technology that uses bacteria to build, chemically stabilise, and test millions of potential drug molecules inside living cells, making it much quicker and easier to discover new treatments for...
Why chronic pain lasts longer in women: Immune cells offer clues
Pain is influenced by sex hormones such as testosterone, a Michigan State University study has discovered.
Chronic pain lasts longer for women than men, and new research has found that differences in hormone-regulated immune cells, called monocytes, may help explain...
Making Pharmaceuticals, Distributing Pharmaceuticals and Making Nutraceuticals 2026
Taking place at the Coventry Building Society Arena on 21-22 April 2026 and free to attend, Making Pharmaceuticals, Distributing Pharmaceuticals and Making Nutraceuticals are co-located events providing professionals from across pharmaceutical and nutraceutical supply chains with a platform for...
Why business resilience is crucial for the bioscience sector
Bioscience businesses operate in one of the most complex and highly regulated risk environments in the global economy. Innovation cycles are long, regulation is exacting, and the consequences of disruption – whether to research, laboratory processes, manufacturing, or supply...
Early signs of Parkinson’s identified in blood
A team led by researchers at Chalmers University of Technology, Sweden, has identified biomarkers for Parkinson’s disease in its earliest stages, before extensive brain damage occurs.
The biological processes leave measurable traces in the blood, but only for a limited...
New test could help pinpoint IBD diagnosis
A test that rapidly detects signs of inflammatory bowel disease (IBD) in stool samples could improve future diagnosis and monitoring of the condition, a study suggests.
Scientists have developed a tool to measure the activity of a molecule linked to...
Discovering why only some early tumours survive could help spot cancer at earliest stages
Cambridge scientists have shown that when tumours first emerge, interactions with healthy cells in the underlying supportive tissue determine their ability to survive, grow, and progress to advanced stages of disease.
The study, carried out in mice and further validated...
Successful ALS treatments are a $143bn opportunity to change lives
Huge advances have been made in our understanding of neurodegenerative diseases – but ALS still has no cure and new investment is urgently needed. By Dr Amanda Cole, Director, Office of Health Economics (OHE).
LS, the most common form of...
World-first AI model launch for programmable gene insertion
The breakthrough – by biotech Basecamp Research – aims to tackle a longstanding challenge in genetic medicine by developing a new generation of curative cell & gene therapies.
These first AI models, capable of programmable gene insertion, offer a new...
How Early Data Drives Better Cell Line Performance
In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory expectations. Yet one factor often determines long-term success more than any other: the strength of the data generated in the earliest...
UK’s £400m largest single-use biomanufacturing facility opens in teeside
FUJIFILM Biotechnologies - a global world leader in biologics, vaccines and advanced therapies - has significantly expanded its Teesside site.
FUJIFILM Biotechnologies - a global world leader in biologics, vaccines and advanced therapies - has significantly expanded its Teesside site.
The...
Training the medicine makers of tomorrow: How virtual reality is securing the UK’s life sciences future
Ivan Wall, is co-director of Resilience, a two-year, £4.3 million UK government scheme using VR to educate the next generation of medicine makers.
As the world marks International Day of Education on 24 January, the UK faces a stark reality:...
Inclusive clinical trials will drive better health outcomes for all
Pharmaceutical research must be much more inclusive and diverse to protect global health, says Kate Shaw, of Innovative Trials.
As a sector, the life sciences industry is driven to innovate. From precision medicines to genome editing and AI-powered molecules, our...
In 2026, precision oncology trials will finally come into their own
Dr Gen Li, CEO and Founder, Phesi, looks at R&D trends for the year ahead.
Oncology indications – particularly breast, prostate and non-small-cell lung cancer – have led Phesi’s annual Most Studied Diseases list for the last four years, and...
Poorer heart health in middle age linked to increased dementia risk
People with signs of damage to their heart during middle age are more likely to develop dementia in later life, according to research funded by the British Heart Foundation and published in the European Heart Journal.1
The study, led by...
Eye prosthesis restores sight
A tiny wireless chip implanted in the back of the eye, together with a pair of high-tech glasses, have partially restored vision to people with an advanced form of age-related macular degeneration.
In a clinical trial led by Stanford Medicine...
Arbitrating innovation: Resolving IP disputes in life sciences
As biotech and AI converge, arbitration is emerging as the preferred forum for complex intellectual property disputes – particularly when the underlying science defies straightforward explanation or analysis. In this exclusive feature, Bernhard Maier, partner and head of arbitration...
At-home brain stimulation ‘prevents major depression relapse’
Up to 85% of people with depression experience relapse during treatment.
However, a new clinical study has found that at-home brain stimulation therapy helped 75% of patients stay depression-free over six months, solving a major gap in mental health care.
The...
One in 4 life sciences professionals don’t know what data their AI models use
Experts from companies including AstraZeneca, Bayer, Novartis, and Vertex shared insights into AI agents, accelerating clinical trials and skills gaps, at a recent US conference.
New data indicates a growing “scientific content crisis” that is limiting the accuracy and adoption...
How chromosomes separate accurately
UNIGE scientists have shed new light on how cell division disorders lead to certain cancers.
Cell division is a process of remarkable precision: during each cycle, the genetic material must be evenly distributed between the two daughter cells.
To achieve this,...
Breaking the bias: Diverse genomics can transform dementia diagnoses
Diagnosis of complex genetic diseases is a global challenge, but genomics research remains disproportionately focused on populations of European ancestry. Inclusive, diverse research could unlock the door to new therapies, says Neil Ward, VP of PacBio EMEA.
Europeans make up...
Doing more with less in R&D: turning equipment usage data into CapEx efficiency
As budgets tighten across life sciences, many R&D organisations have realised their biggest source of waste isn’t in their science, but their operations. Johannes Solzbach, CEO and co-founder at Calira, believes greater visibility of equipment usage data can help...
Principal Investigators: The fuel of scientific progress
PIs are crucial to maintaining research integrity, says Dekel Faruhi, VP of Product Adoption at Proofig AI.
The path to becoming a Principal Investigator (PI) usually takes over a decade, beginning with undergraduate studies and culminating in the acquisition of...
AI hallucinations are eroding trust in lab tools – but there are solutions
As scientists and researchers seek to integrate AI more deeply into daily lab workflows, tackling the issue of false or misleading information has become a top priority, says Andrew Wyatt, Chief Growth Officer, Sapio Sciences.
AI is increasingly important for...
How an AI powered implant is rewriting neurological care
The frontier of neurology has begun to think for itself.
The claim follows pioneering brain surgery carried out at King Faisal Specialist Hospital and Research Centre (KFSHRC).
In June 2025, surgeons at the centre, in Riyadh, Saudi Arabia, implanted the Middle...
Next-gen medical devices could run on body’s natural sugars
A new generation of implantable medical devices powered by natural sugars in the body could help treat life-long conditions like neurodegenerative diseases, diabetes and heart conditions.
The GLUTRONICS research project, which has received over £2 million in funding, is led...
DNA molecules manoeuvred using electrical fields
New tool offers real-time control over genetic materials, with potential to accelerate disease diagnostics and genome mapping
Researchers in McGill’s Department of Physics have developed a device that can trap and study DNA molecules without touching or damaging them.
The device,...
Without the right infrastructure, the UK risks falling behind in life sciences
Dr Kath Mackay, Chief Scientific Officer at Bruntwood SciTech, insists that investment in scientific talent and research is not enough on its own. To stay globally competitive in life sciences, the UK must invest in the infrastructure and ecosystems...
Why life sciences must build Recall Ready systems now
From paracetamol contamination to failing defibrillators, recent recall events show how fragile response mechanisms remain. Pete Gillett, founder of Marketpoint Recall, explores why life sciences firms must modernise recall operations before regulatory, financial and reputational costs spiral further.
In mid‑2025,...
